nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—CHRM2—type 1 diabetes mellitus	0.569	0.745	CbGaD
Nortriptyline—ALB—type 1 diabetes mellitus	0.195	0.255	CbGaD
Nortriptyline—HTR2A—arteriole—type 1 diabetes mellitus	0.00329	0.139	CbGeAlD
Nortriptyline—Hepatic necrosis—Ramipril—type 1 diabetes mellitus	0.00312	0.0502	CcSEcCtD
Nortriptyline—Inappropriate antidiuretic hormone secretion—Ramipril—type 1 diabetes mellitus	0.00312	0.0502	CcSEcCtD
Nortriptyline—ORM1—saliva—type 1 diabetes mellitus	0.00305	0.129	CbGeAlD
Nortriptyline—Bone marrow depression—Ramipril—type 1 diabetes mellitus	0.00269	0.0432	CcSEcCtD
Nortriptyline—SLC6A2—autonomic nervous system—type 1 diabetes mellitus	0.00234	0.0994	CbGeAlD
Nortriptyline—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00162	0.0261	CcSEcCtD
Nortriptyline—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00147	0.0237	CcSEcCtD
Nortriptyline—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00142	0.0228	CcSEcCtD
Nortriptyline—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.00141	0.0597	CbGeAlD
Nortriptyline—Purpura—Ramipril—type 1 diabetes mellitus	0.00137	0.022	CcSEcCtD
Nortriptyline—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00134	0.0216	CcSEcCtD
Nortriptyline—SLC6A2—nerve—type 1 diabetes mellitus	0.00132	0.0559	CbGeAlD
Nortriptyline—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00131	0.021	CcSEcCtD
Nortriptyline—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.0012	0.0193	CcSEcCtD
Nortriptyline—DRD2—nerve—type 1 diabetes mellitus	0.0012	0.0509	CbGeAlD
Nortriptyline—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00113	0.0181	CcSEcCtD
Nortriptyline—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00111	0.0178	CcSEcCtD
Nortriptyline—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00108	0.0174	CcSEcCtD
Nortriptyline—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00105	0.0168	CcSEcCtD
Nortriptyline—Weight increased—Ramipril—type 1 diabetes mellitus	0.00104	0.0166	CcSEcCtD
Nortriptyline—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.00102	0.0431	CbGeAlD
Nortriptyline—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.001	0.0161	CcSEcCtD
Nortriptyline—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.000994	0.016	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.000994	0.016	CcSEcCtD
Nortriptyline—Stomatitis—Ramipril—type 1 diabetes mellitus	0.000989	0.0159	CcSEcCtD
Nortriptyline—Jaundice—Ramipril—type 1 diabetes mellitus	0.000989	0.0159	CcSEcCtD
Nortriptyline—Sweating—Ramipril—type 1 diabetes mellitus	0.000972	0.0156	CcSEcCtD
Nortriptyline—Dimetindene—CHRM2—type 1 diabetes mellitus	0.00097	0.19	CrCbGaD
Nortriptyline—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.000946	0.0152	CcSEcCtD
Nortriptyline—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00091	0.0146	CcSEcCtD
Nortriptyline—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000897	0.0144	CcSEcCtD
Nortriptyline—Tinnitus—Ramipril—type 1 diabetes mellitus	0.000849	0.0137	CcSEcCtD
Nortriptyline—Flushing—Ramipril—type 1 diabetes mellitus	0.000845	0.0136	CcSEcCtD
Nortriptyline—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.000813	0.0131	CcSEcCtD
Nortriptyline—Alopecia—Ramipril—type 1 diabetes mellitus	0.000804	0.0129	CcSEcCtD
Nortriptyline—HTR2A—nerve—type 1 diabetes mellitus	0.000791	0.0336	CbGeAlD
Nortriptyline—Tension—Ramipril—type 1 diabetes mellitus	0.000778	0.0125	CcSEcCtD
Nortriptyline—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000776	0.0125	CcSEcCtD
Nortriptyline—Nervousness—Ramipril—type 1 diabetes mellitus	0.00077	0.0124	CcSEcCtD
Nortriptyline—Maprotiline—CHRM2—type 1 diabetes mellitus	0.000749	0.147	CrCbGaD
Nortriptyline—ADRA1B—kidney—type 1 diabetes mellitus	0.000747	0.0317	CbGeAlD
Nortriptyline—Tremor—Ramipril—type 1 diabetes mellitus	0.000743	0.0119	CcSEcCtD
Nortriptyline—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.000735	0.0118	CcSEcCtD
Nortriptyline—Agitation—Ramipril—type 1 diabetes mellitus	0.000728	0.0117	CcSEcCtD
Nortriptyline—Malaise—Ramipril—type 1 diabetes mellitus	0.000715	0.0115	CcSEcCtD
Nortriptyline—Syncope—Ramipril—type 1 diabetes mellitus	0.000711	0.0114	CcSEcCtD
Nortriptyline—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000709	0.0114	CcSEcCtD
Nortriptyline—Palpitations—Ramipril—type 1 diabetes mellitus	0.0007	0.0113	CcSEcCtD
Nortriptyline—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000697	0.0112	CcSEcCtD
Nortriptyline—Convulsion—Ramipril—type 1 diabetes mellitus	0.000687	0.011	CcSEcCtD
Nortriptyline—Anxiety—Ramipril—type 1 diabetes mellitus	0.000672	0.0108	CcSEcCtD
Nortriptyline—Discomfort—Ramipril—type 1 diabetes mellitus	0.000667	0.0107	CcSEcCtD
Nortriptyline—Cyproheptadine—CHRM2—type 1 diabetes mellitus	0.000665	0.13	CrCbGaD
Nortriptyline—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00066	0.0106	CcSEcCtD
Nortriptyline—Confusional state—Ramipril—type 1 diabetes mellitus	0.000652	0.0105	CcSEcCtD
Nortriptyline—Oedema—Ramipril—type 1 diabetes mellitus	0.000647	0.0104	CcSEcCtD
Nortriptyline—Shock—Ramipril—type 1 diabetes mellitus	0.000636	0.0102	CcSEcCtD
Nortriptyline—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000633	0.0102	CcSEcCtD
Nortriptyline—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000631	0.0102	CcSEcCtD
Nortriptyline—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000625	0.0101	CcSEcCtD
Nortriptyline—Anorexia—Ramipril—type 1 diabetes mellitus	0.000617	0.00991	CcSEcCtD
Nortriptyline—Hypotension—Ramipril—type 1 diabetes mellitus	0.000604	0.00972	CcSEcCtD
Nortriptyline—Insomnia—Ramipril—type 1 diabetes mellitus	0.000585	0.00941	CcSEcCtD
Nortriptyline—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000581	0.00934	CcSEcCtD
Nortriptyline—Somnolence—Ramipril—type 1 diabetes mellitus	0.000575	0.00925	CcSEcCtD
Nortriptyline—CHRM2—cardiovascular system—type 1 diabetes mellitus	0.000573	0.0243	CbGeAlD
Nortriptyline—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000569	0.00916	CcSEcCtD
Nortriptyline—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000562	0.00904	CcSEcCtD
Nortriptyline—Fatigue—Ramipril—type 1 diabetes mellitus	0.000558	0.00897	CcSEcCtD
Nortriptyline—Constipation—Ramipril—type 1 diabetes mellitus	0.000553	0.00889	CcSEcCtD
Nortriptyline—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000533	0.00857	CcSEcCtD
Nortriptyline—CHRM1—cardiovascular system—type 1 diabetes mellitus	0.000522	0.0222	CbGeAlD
Nortriptyline—Urticaria—Ramipril—type 1 diabetes mellitus	0.000514	0.00826	CcSEcCtD
Nortriptyline—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000511	0.00822	CcSEcCtD
Nortriptyline—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000511	0.00822	CcSEcCtD
Nortriptyline—DRD2—retina—type 1 diabetes mellitus	0.000497	0.0211	CbGeAlD
Nortriptyline—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000477	0.00766	CcSEcCtD
Nortriptyline—CYP3A5—islet of Langerhans—type 1 diabetes mellitus	0.000473	0.0201	CbGeAlD
Nortriptyline—HTR1A—cardiovascular system—type 1 diabetes mellitus	0.000465	0.0198	CbGeAlD
Nortriptyline—Asthenia—Ramipril—type 1 diabetes mellitus	0.000464	0.00746	CcSEcCtD
Nortriptyline—Chlorprothixene—CHRM2—type 1 diabetes mellitus	0.000459	0.09	CrCbGaD
Nortriptyline—Pruritus—Ramipril—type 1 diabetes mellitus	0.000458	0.00736	CcSEcCtD
Nortriptyline—CHRM3—kidney—type 1 diabetes mellitus	0.000457	0.0194	CbGeAlD
Nortriptyline—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000443	0.00712	CcSEcCtD
Nortriptyline—ADRA1A—cardiovascular system—type 1 diabetes mellitus	0.000429	0.0182	CbGeAlD
Nortriptyline—Dizziness—Ramipril—type 1 diabetes mellitus	0.000428	0.00688	CcSEcCtD
Nortriptyline—Vomiting—Ramipril—type 1 diabetes mellitus	0.000411	0.00661	CcSEcCtD
Nortriptyline—Rash—Ramipril—type 1 diabetes mellitus	0.000408	0.00656	CcSEcCtD
Nortriptyline—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000407	0.00655	CcSEcCtD
Nortriptyline—Headache—Ramipril—type 1 diabetes mellitus	0.000405	0.00652	CcSEcCtD
Nortriptyline—Doxepin—CHRM2—type 1 diabetes mellitus	0.000404	0.0792	CrCbGaD
Nortriptyline—Nausea—Ramipril—type 1 diabetes mellitus	0.000384	0.00618	CcSEcCtD
Nortriptyline—CYP3A5—nephron tubule—type 1 diabetes mellitus	0.000381	0.0162	CbGeAlD
Nortriptyline—Desipramine—CHRM2—type 1 diabetes mellitus	0.000371	0.0727	CrCbGaD
Nortriptyline—ADRA1A—lymphoid tissue—type 1 diabetes mellitus	0.00036	0.0153	CbGeAlD
Nortriptyline—CYP2E1—nephron tubule—type 1 diabetes mellitus	0.000355	0.0151	CbGeAlD
Nortriptyline—CYP2C9—cardiovascular system—type 1 diabetes mellitus	0.000337	0.0143	CbGeAlD
Nortriptyline—CYP3A5—kidney—type 1 diabetes mellitus	0.000335	0.0142	CbGeAlD
Nortriptyline—CYP3A5—pancreas—type 1 diabetes mellitus	0.000332	0.0141	CbGeAlD
Nortriptyline—HTR2A—retina—type 1 diabetes mellitus	0.000328	0.0139	CbGeAlD
Nortriptyline—CYP2E1—cardiovascular system—type 1 diabetes mellitus	0.000319	0.0135	CbGeAlD
Nortriptyline—Desipramine—ADRB1—type 1 diabetes mellitus	0.000316	0.062	CrCbGaD
Nortriptyline—Imipramine—CHRM2—type 1 diabetes mellitus	0.000314	0.0617	CrCbGaD
Nortriptyline—Amitriptyline—CHRM2—type 1 diabetes mellitus	0.000312	0.0613	CrCbGaD
Nortriptyline—CYP2E1—kidney—type 1 diabetes mellitus	0.000312	0.0133	CbGeAlD
Nortriptyline—PTGS1—cardiovascular system—type 1 diabetes mellitus	0.000307	0.013	CbGeAlD
Nortriptyline—PTGS1—kidney—type 1 diabetes mellitus	0.000301	0.0128	CbGeAlD
Nortriptyline—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.000277	0.0118	CbGeAlD
Nortriptyline—Oxcarbazepine—ALB—type 1 diabetes mellitus	0.000275	0.0539	CrCbGaD
Nortriptyline—HTR2A—kidney—type 1 diabetes mellitus	0.000271	0.0115	CbGeAlD
Nortriptyline—CYP2E1—lymphoid tissue—type 1 diabetes mellitus	0.000268	0.0114	CbGeAlD
Nortriptyline—CYP3A4—kidney—type 1 diabetes mellitus	0.000251	0.0107	CbGeAlD
Nortriptyline—CYP2D6—kidney—type 1 diabetes mellitus	0.000247	0.0105	CbGeAlD
Nortriptyline—Clomipramine—ALB—type 1 diabetes mellitus	0.000158	0.0309	CrCbGaD
Nortriptyline—Amitriptyline—ALB—type 1 diabetes mellitus	0.000107	0.021	CrCbGaD
Nortriptyline—ADRA1D—Signaling Pathways—CD80—type 1 diabetes mellitus	1.05e-05	7.2e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.04e-05	7.17e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.04e-05	7.16e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.04e-05	7.16e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.03e-05	7.11e-05	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.03e-05	7.1e-05	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.03e-05	7.08e-05	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.03e-05	7.06e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.03e-05	7.05e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	1.02e-05	7.04e-05	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.02e-05	7.04e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.02e-05	7.04e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	1.02e-05	7.03e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.02e-05	7.03e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.02e-05	7.02e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.02e-05	7e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	1.02e-05	7e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.02e-05	6.99e-05	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.01e-05	6.97e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.01e-05	6.97e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.01e-05	6.95e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.01e-05	6.92e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	1e-05	6.91e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	9.99e-06	6.87e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—INS—type 1 diabetes mellitus	9.96e-06	6.85e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	9.95e-06	6.84e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.9e-06	6.81e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—INS—type 1 diabetes mellitus	9.89e-06	6.8e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.82e-06	6.75e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.74e-06	6.7e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.74e-06	6.7e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.72e-06	6.69e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.69e-06	6.67e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.66e-06	6.65e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CAT—type 1 diabetes mellitus	9.64e-06	6.63e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.64e-06	6.63e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.6e-06	6.6e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.58e-06	6.59e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.57e-06	6.58e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.57e-06	6.58e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.56e-06	6.58e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.54e-06	6.56e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.53e-06	6.56e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.53e-06	6.55e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.52e-06	6.55e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.5e-06	6.54e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.45e-06	6.5e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.43e-06	6.48e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.41e-06	6.47e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.4e-06	6.47e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	9.4e-06	6.46e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.4e-06	6.46e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.38e-06	6.45e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.37e-06	6.45e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.37e-06	6.44e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.35e-06	6.43e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.32e-06	6.41e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	9.32e-06	6.41e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.29e-06	6.39e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.27e-06	6.38e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.25e-06	6.36e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.23e-06	6.35e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	9.21e-06	6.33e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.2e-06	6.33e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.18e-06	6.31e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—ALB—type 1 diabetes mellitus	9.13e-06	6.28e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	9.13e-06	6.28e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CD80—type 1 diabetes mellitus	9.08e-06	6.24e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.84e-06	6.08e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—INS—type 1 diabetes mellitus	8.83e-06	6.07e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—NOS3—type 1 diabetes mellitus	8.73e-06	6.01e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CD80—type 1 diabetes mellitus	8.69e-06	5.98e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.68e-06	5.97e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.67e-06	5.96e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL2—type 1 diabetes mellitus	8.66e-06	5.96e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	8.65e-06	5.95e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	8.62e-06	5.93e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.62e-06	5.93e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—INS—type 1 diabetes mellitus	8.58e-06	5.9e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	8.4e-06	5.77e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.34e-06	5.74e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.3e-06	5.71e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.3e-06	5.71e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.26e-06	5.68e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—INS—type 1 diabetes mellitus	8.21e-06	5.65e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.18e-06	5.63e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL2—type 1 diabetes mellitus	8.17e-06	5.62e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.13e-06	5.59e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—ALB—type 1 diabetes mellitus	8.1e-06	5.57e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	8.01e-06	5.51e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	7.96e-06	5.48e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	7.96e-06	5.47e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.94e-06	5.46e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.9e-06	5.44e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	7.9e-06	5.43e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	7.89e-06	5.42e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	7.88e-06	5.42e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CD80—type 1 diabetes mellitus	7.87e-06	5.41e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	7.85e-06	5.4e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	7.84e-06	5.39e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.83e-06	5.39e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL2—type 1 diabetes mellitus	7.82e-06	5.38e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CD80—type 1 diabetes mellitus	7.82e-06	5.38e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.78e-06	5.35e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—NOS3—type 1 diabetes mellitus	7.75e-06	5.33e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CD80—type 1 diabetes mellitus	7.74e-06	5.32e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	7.72e-06	5.31e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	7.71e-06	5.3e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.7e-06	5.3e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.66e-06	5.27e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	7.57e-06	5.21e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.56e-06	5.2e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.52e-06	5.17e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	7.45e-06	5.12e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—INS—type 1 diabetes mellitus	7.44e-06	5.12e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—INS—type 1 diabetes mellitus	7.43e-06	5.11e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—INS—type 1 diabetes mellitus	7.43e-06	5.11e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—INS—type 1 diabetes mellitus	7.41e-06	5.1e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—INS—type 1 diabetes mellitus	7.39e-06	5.08e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.37e-06	5.07e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL2—type 1 diabetes mellitus	7.35e-06	5.06e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.34e-06	5.05e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.32e-06	5.04e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.32e-06	5.03e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—INS—type 1 diabetes mellitus	7.31e-06	5.03e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	7.29e-06	5.02e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.29e-06	5.01e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.29e-06	5.01e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.21e-06	4.96e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.2e-06	4.95e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.19e-06	4.94e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.17e-06	4.93e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.17e-06	4.93e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.15e-06	4.92e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.14e-06	4.91e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.13e-06	4.9e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.11e-06	4.89e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.07e-06	4.87e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.05e-06	4.85e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.04e-06	4.84e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.02e-06	4.83e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.87e-06	4.73e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—ALB—type 1 diabetes mellitus	6.82e-06	4.69e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—ALB—type 1 diabetes mellitus	6.81e-06	4.68e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.76e-06	4.65e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	6.74e-06	4.64e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.66e-06	4.58e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.64e-06	4.57e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.64e-06	4.57e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.62e-06	4.55e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.62e-06	4.55e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.6e-06	4.54e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.58e-06	4.53e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.53e-06	4.49e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.53e-06	4.49e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—NOS3—type 1 diabetes mellitus	6.53e-06	4.49e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.52e-06	4.48e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.52e-06	4.48e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—NOS3—type 1 diabetes mellitus	6.51e-06	4.48e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.5e-06	4.47e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.48e-06	4.45e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.42e-06	4.42e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.41e-06	4.41e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	6.41e-06	4.41e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—INS—type 1 diabetes mellitus	6.4e-06	4.4e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.4e-06	4.4e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.39e-06	4.39e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.38e-06	4.39e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL2—type 1 diabetes mellitus	6.38e-06	4.39e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.35e-06	4.36e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.25e-06	4.3e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.19e-06	4.26e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	6.14e-06	4.23e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.11e-06	4.2e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL2—type 1 diabetes mellitus	6.1e-06	4.2e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.07e-06	4.18e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.98e-06	4.11e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	5.74e-06	3.95e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.64e-06	3.88e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	5.63e-06	3.87e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.63e-06	3.87e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—NOS3—type 1 diabetes mellitus	5.61e-06	3.86e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.6e-06	3.85e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.55e-06	3.81e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	5.54e-06	3.81e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.53e-06	3.81e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL2—type 1 diabetes mellitus	5.53e-06	3.8e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.52e-06	3.79e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.51e-06	3.79e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	5.51e-06	3.79e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.5e-06	3.78e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.5e-06	3.78e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL2—type 1 diabetes mellitus	5.49e-06	3.78e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.48e-06	3.77e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.46e-06	3.76e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.45e-06	3.75e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL2—type 1 diabetes mellitus	5.44e-06	3.74e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.43e-06	3.73e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	5.42e-06	3.73e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.41e-06	3.72e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.4e-06	3.71e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.39e-06	3.71e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.37e-06	3.69e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	5.28e-06	3.63e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	5.26e-06	3.62e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	5.24e-06	3.6e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	5.2e-06	3.58e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.14e-06	3.53e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL6—type 1 diabetes mellitus	5.09e-06	3.5e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	5.04e-06	3.46e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.9e-06	3.37e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.88e-06	3.35e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	4.84e-06	3.33e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL6—type 1 diabetes mellitus	4.8e-06	3.3e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	4.8e-06	3.3e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.74e-06	3.26e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.67e-06	3.21e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.66e-06	3.2e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.65e-06	3.2e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.63e-06	3.19e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	4.63e-06	3.19e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.62e-06	3.18e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL6—type 1 diabetes mellitus	4.6e-06	3.16e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	4.59e-06	3.16e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.58e-06	3.15e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.56e-06	3.14e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	4.47e-06	3.08e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL6—type 1 diabetes mellitus	4.32e-06	2.97e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.3e-06	2.96e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.24e-06	2.91e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.23e-06	2.91e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.21e-06	2.9e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.2e-06	2.89e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.16e-06	2.86e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.15e-06	2.85e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	4.1e-06	2.82e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	3.92e-06	2.7e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.77e-06	2.59e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL6—type 1 diabetes mellitus	3.75e-06	2.58e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL6—type 1 diabetes mellitus	3.59e-06	2.47e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	3.45e-06	2.37e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	3.31e-06	2.28e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.25e-06	2.24e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.25e-06	2.23e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.24e-06	2.23e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL6—type 1 diabetes mellitus	3.23e-06	2.22e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL6—type 1 diabetes mellitus	3.2e-06	2.2e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.19e-06	2.19e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	3.17e-06	2.18e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	3.03e-06	2.08e-05	CbGpPWpGaD
